Project Grant HT94252410717
Award Date 9/30/24
Completion Date 9/29/26
Dollars Obligated $566K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
- Federal Project Grant Award Summary Award: The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded Duke University's Office of Research Administration a Project Grant of $564,705 on September 15, 2025, for research extending through September 14, 2028. The award supports the identification of oncofusion-interacting proteins as essential drug targets for common and rare oncofusions in rhabdomyosarcoma. This research initiative aligns...
- This $828,591 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Duke University to target the tumor microenvironment and enhance immunotherapy for small cell lung cancer (SCLC). The award period runs from May 1, 2025 to April 30, 2027. As a leading private research institution, Duke University's Office of Research Administration will leverage its multidisciplinary scientific expertise to advance medical...
- Duke University's Office of Research Administration received a $960,626 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2027. The award supports research investigating NUAK2 as a novel splicing regulatory kinase in neuroendocrine prostate cancer. This research initiative delivers translational and basic biomedical research services designed to advance understanding...
- The U.S. Defense Health Agency awarded a $437,975 Project Grant to the University of New South Wales, doing business as The University of NSW, to conduct research on "TARGETING THE NOVEL LONG NONCODING RNA PRKCQ-AS1 FOR CANCER THERAPY". This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for U.S. Service Members and the public. The funded research aims...
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $845,250 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning July 1, 2025, through June 30, 2028. The project focuses on engineering T-cell receptor (TCR)-modified T cells designed to target human endogenous retroviruses for non-small cell lung cancer immunotherapy. This research initiative represents an advanced biomedical research...
- The Department of the Army Medical Command awarded Duke University a $547,664 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 to May 2023 to exploit targeted therapy-induced ATM dependence in residual lung tumors. Through this award, Duke University researchers will investigate medical solutions for the battlefield by transforming health care for Service Members and the American public through innovative and...
- The Department of Defense's Defense Health Agency awarded a $4,818,759 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) for the project "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant, awarded on April 1, 2024, will fund research to improve understanding and treatment of lethal breast cancers through advanced single-cell and spatial analysis techniques. This work supports the program's goals of...
- The Defense Health Agency awarded Duke University a $3,811,150.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant period runs from April 1, 2024 to March 31, 2028. The key products and services to be delivered under this award include comprehensive single-cell and spatial analysis of breast cancer samples to characterize tumor heterogeneity...
- This $161,000 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Duke University to investigate "Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes." The research aims to develop innovative approaches to understand complex biological systems, create new diagnostic tools, and explore potential therapeutic interventions...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $240,897 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, with a completion date of July 31, 2027. The award funds integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma (SEGA) at single-cell resolution. This research initiative delivers advanced molecular...